期刊文献+

昼夜节律变化对动脉粥样硬化形成的影响及其相关通路的研究进展

Research progress of circadian rhythm and related pathways in atherosclerosis
下载PDF
导出
摘要 地球上几乎所有的生命都存在昼夜节律,控制昼夜节律的生物钟具有重要的生理功能,同时也是疾病的重要调节器。昼夜节律与动脉粥样硬化关系密切。研究表明受损的生物钟会影响造血过程和糖脂代谢,并改变局部斑块病变中的细胞功能。在分子水平上,昼夜节律可以通过Toll样受体(TLR)通路调节动脉粥样硬化炎症状态和血管重塑,通过蛋白激酶B(Akt)通路改善内皮功能和胰岛素信号传导,并通过CCL2-CCR2信号轴影响单核细胞的招募与淋巴细胞的活化。本篇综述讨论了动脉粥样硬化中昼夜节律的作用及分子机制,以及动脉粥样硬化与生物钟系统的联系。 Almost all life on earth has an internal mechanism-circadian rhythm,and the circadian clock that controls the circadian rhythm has been revealed as an important regulator of physiology and disease.Circadian rhythm is closely related to atherosclerosis(As).Various studies have shown that impaired circadian clocks and disturbed sleep can affect hematopoiesis process and glucose and lipid metabolism of As,and change the cellular behavior in local plaque lesions.At the molecular level,circadian rhythm can regulate atherosclerotic inflammation and vascular remodeling through the Toll like receptor(TLR)pathway,improve endothelial function and insulin signaling through the protein kinase B(Akt)pathway,and affect the recruitment of monocytes and activation of lymphocytes through the CCL2-CCR2 signal axis.This review discussed the role and molecular mechanisms of circadian rhythm in As,in order to better understand the connection between As and the circadian clock system.
作者 王文婷 李兆钰 郭超 王琳 吴斯佳 张星 董峰 彭波 李晓 WANG Wenting;LI Zhaoyu;GUO Chao;WANG Lin;WU Sijia;ZHANG Xing;DONG Feng;PENG Bo;LI Xiao(The First Clinical Medical College,Shandong University of Traditional Chinese Medicine;Department of Cardiology,Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Jinan,Shandong 250014,China)
出处 《中国动脉硬化杂志》 CAS 2021年第9期814-818,共5页 Chinese Journal of Arteriosclerosis
基金 国家自然科学基金项目(81874449) 山东省重点研发计划(2019GSF108024)。
关键词 动脉粥样硬化 昼夜节律 生物钟 atherosclerosis circadian rhythm circadian clock
  • 相关文献

参考文献3

二级参考文献40

  • 1Vincent G DeMarco,Adam T Whaley-Connell,James R Sowers,Javad Habibi,Kevin C Dellsperger.Contribution of oxidative stress to pulmonary arterial hypertension[J].World Journal of Cardiology,2010,2(10):316-324. 被引量:21
  • 2Miller YI, Choi SH, Wiesner P, et al. The SYK side of TLR4 : Sig- naling mechanisms in response to LPS and minimally oxidized LDL [J]. Br J Pharmacol, 2012, 167 (5): 990-999. 被引量:1
  • 3Miller YI, Choi SH, Fang LH, et al. Toll-like receptor-4 and lipo- protein accumulation in macrophages [J]. Trends Cardiovasc Med, 2009, 19 (7) : 227-232. 被引量:1
  • 4Steinberg D, Witztum JL. Oxidized low-density lipoprotein and ath- erosclerosis[J]. Arterioscler Thromb Vasc Biol, 2010, 30:2 311-316. 被引量:1
  • 5Maiolino G, Rossitto G, Caielli P, et al. The role of oxidized low- density lipoproteins in atherosclerosis: The myths and the facts[J]. Mediators of Inflammation Volume, 2013, Article ID 714653, dx. doi. org/10. 1155/2013/714653. 被引量:1
  • 6Johnston N, Jernberg T, Lagerqvist B, et al. Oxidized low-density lipoprotein as a predictor of outcome in patients with unstable coro- nary artery disease[J]. Int J Cardiol, 2006, 113 (2) : 167-173. 被引量:1
  • 7Lee YK, Lee HD, Kim JK, et al. Lysophosphatidylcholine, oxi- dized low-density lipoprotein and cardiovascular disease in korean hemodialysis patients: analysis at 5 years of follow-up[J]. J Korean Med Sci, 2013, 28 : 268-273. 被引量:1
  • 8Liao F, Berliner JA, Mehrabian M, et al. Minimally modified low- density lipoprotein is biologically active in vivo in mice [J]. J Clin Invest, 1991:87 (6): 2 253-257. 被引量:1
  • 9Harkewicz R, Hartvigsen K, Almazan F, et al. Cholesteryl ester hy- droperoxides are biologically active components of minimally oxidized low density lipoprotein[J]. Biol Chem, 2008, 283 : 10 241-251. 被引量:1
  • 10Huo Y, Zhao L, Hyman MC, et al. Critical role of macrophage 12/15-1ipoxygenase for atherosclerosis in apolipoprotein e-deficient mice[J]. Circulation, 2004, 110:2 024-031. 被引量:1

共引文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部